Humoral complementomics – exploration of noninvasive complement biomarkers as predictors of renal cancer progression
ABSTRACTDespite the progress of anti-cancer treatment, the prognosis of many patients with solid tumors is still dismal. Reliable noninvasive biomarkers are needed to predict patient survival and therapy response. Here, we propose a Humoral Complementomics approach: a work-up of assays to comprehens...
Main Authors: | Margot Revel, Mikel Rezola Artero, Houcine Hamidi, Anne Grunenwald, Loris Blasco, Yann A. Vano, Stephane Marie Oudard, Rafael Sanchez-Salas, Petr Macek, Lara Rodriguez Sanchez, Xavier Cathelineau, Benoit Vedié, Catherine Sautes-Fridman, Wolf Herman Fridman, Lubka T. Roumenina, Marie-Agnes Dragon-Durey |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2024.2328433 |
Similar Items
-
Complement System: Promoter or Suppressor of Cancer Progression?
by: Margot Revel, et al.
Published: (2020-10-01) -
Autoantibodies against Complement Classical Pathway Components C1q, C1r, C1s and C1-Inh in Patients with Lupus Nephritis
by: Maria Radanova, et al.
Published: (2022-08-01) -
Complement as a vital nexus of the pathobiological connectome for acute respiratory distress syndrome: An emerging therapeutic target
by: Zhangsheng Yang, et al.
Published: (2023-03-01) -
Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance?
by: Marco Mannes, et al.
Published: (2023-03-01) -
Editorial: The complement system in autoimmunity
by: Eveline Y. Wu, et al.
Published: (2022-11-01)